Shared Decision for Drug Interactions in Oral Anticoagulation

Launched by UNIVERSITY OF UTAH · May 5, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on improving how doctors and patients make decisions about using blood-thinning medications called anticoagulants. The study will test a new tool called DDInteract, which helps identify potential interactions between different medications that patients might be taking. This tool will be used in clinics at the University of Utah, University of Colorado, and Vanderbilt University, and it will pull information from patients' medical records to calculate risks and explore different treatment options together with healthcare providers. The goal is to make sure patients receive the safest and most effective care while on anticoagulants.

To participate in this trial, individuals need to be at least 21 years old and currently taking more than one type of anticoagulant, such as warfarin or apixaban. Unfortunately, those who do not speak English or Spanish will not be eligible. Participants can expect to be involved in discussions about their treatment options, which will include personalized information on the benefits and risks of their medications. This trial is currently active, but it is not recruiting new participants at this time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Be at least 21 years of age or older
• • Receive more than one prescription of an oral anticoagulant (i.e. warfarin, apixaban, edoxaban, dabigatran, rivaroxaban)
• Exclusion Criteria:
• • Individuals not able to speak English or Spanish